Related Experiment Video
Updated: Jul 5, 2025
07:17
Purification of Hsp104, a Protein Disaggregase
Published on: September 30, 2011
17.4K
Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones
Mohammed Iqbal1, Shea-Lorane Lewis1, Shivani Padhye1
1Department of Pharmaceutical Sciences, USF-Health Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.
Biomolecules
|January 23, 2024
Summary
Alzheimer's disease is complex, but chaperone proteins like Hsp90 offer promising therapeutic avenues. These proteins aid in correct amyloid-β folding and inhibit aggregation, potentially slowing disease progression.
Area of Science:
- Neurodegenerative diseases
- Molecular biology
- Protein homeostasis
Background:
- Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no cure.
- AD pathogenesis involves amyloid-β (Aβ) misfolding and aggregation, and tau protein abnormalities.
- Current treatments offer limited success, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review recent findings (2020-2023) on chaperone proteins in Alzheimer's disease.
- To explore the role of chaperones in regulating amyloid-β processing and aggregation.
- To highlight Hsp90, BRICHOS, and novel chaperones as potential therapeutic targets.
Main Methods:
- Literature review of studies published between 2020 and 2023.
- Analysis of molecular mechanisms underlying Aβ regulation by specific chaperones.
- Synthesis of current knowledge on chaperone-mediated cellular homeostasis in AD.
Main Results:
- Chaperone proteins, particularly heat shock proteins (Hsps), are crucial for correct protein folding and preventing aggregation.
- Hsp90 plays a significant role in maintaining cellular homeostasis and protein folding.
- BRICHOS and other novel chaperones show potential in modulating Aβ aggregation.
Conclusions:
- Understanding chaperone protein functions is key to developing new Alzheimer's disease therapies.
- Targeting chaperones like Hsp90 offers a promising strategy to combat Aβ pathology.
- Further research into novel chaperones may reveal new therapeutic avenues for Alzheimer's disease.
Keywords:
Alzheimer’s diseaseBRICHOS domain chaperoneHsp90amyloid-β proteinartificial chaperonechemical chaperoneengineerable chaperoneMore Related Videos
Related Concept Videos
03:00Molecular Chaperones and Protein Folding
18.0K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.0K
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:32Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
02:41Protein Complex Assembly
10.6K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
10.6K
01:27Post-translational Translocation of Proteins to the RER
5.7K
A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
5.7K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K